AstraZeneca PLC (AZN)

Ratios (Summary)

AstraZeneca PLC, liquidity ratios

	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Current ratio	1.37	1.49	1.50	1.35	1.21
Quick ratio	1.08	1.25	1.16	1.04	0.84
Cash ratio	0.61	0.75	0.75	0.65	0.35

Source: Based on data from AstraZeneca PLC Annual Reports

Ratio	Description	The company
Current ratio	A liquidity ratio calculated as current assets divided by current liabilities.	AstraZeneca PLC's current ratio deteriorated from 2010 to 2011 and from 2011 to 2012.
Quick ratio	A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities.	AstraZeneca PLC's quick ratio improved from 2010 to 2011 but then deteriorated significantly from 2011 to 2012.
Cash ratio	A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities.	AstraZeneca PLC's cash ratio improved from 2010 to 2011 but then deteriorated significantly from 2011 to 2012.

	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Selected Financial Data (USD $ in millions)
Current assets	19,048	23,506	25,131	23,760	16,152
Current liabilities	13,903	15,752	16,787	17,640	13,320
Current Ratio, Comparison to Industry
AstraZeneca PLC¹	1.37	1.49	1.50	1.35	1.21
Industry, Health Care	1.55	1.59	1.62	1.64	1.44

Source: Based on data from AstraZeneca PLC Annual Reports

2012 Calculations

¹ Current ratio = Current assets ÷ Current liabilities
= 19,048 ÷ 13,903 = 1.37

Ratio	Description	The company
Current ratio	A liquidity ratio calculated as current assets divided by current liabilities.	AstraZeneca PLC's current ratio deteriorated from 2010 to 2011 and from 2011 to 2012.

	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Selected Financial Data (USD $ in millions)
Trade receivables, less amounts provided for doubtful debts	5,696	6,630	6,247	5,782	5,558
Other receivables	835	1,237	671	1,197	1,022
Other investments	823	4,248	1,482	1,484	388
Cash and cash equivalents	7,701	7,571	11,068	9,918	4,286
Total quick assets	15,055	19,686	19,468	18,381	11,254
Current liabilities	13,903	15,752	16,787	17,640	13,320
Quick Ratio, Comparison to Industry
AstraZeneca PLC¹	1.08	1.25	1.16	1.04	0.84
Industry, Health Care	1.08	1.14	1.14	1.13	0.98

Source: Based on data from AstraZeneca PLC Annual Reports

2012 Calculations

¹ Quick ratio = Total quick assets ÷ Current liabilities
= 15,055 ÷ 13,903 = 1.08

Ratio	Description	The company
Quick ratio	A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities.	AstraZeneca PLC's quick ratio improved from 2010 to 2011 but then deteriorated significantly from 2011 to 2012.

	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Selected Financial Data (USD $ in millions)
Other investments	823	4,248	1,482	1,484	388
Cash and cash equivalents	7,701	7,571	11,068	9,918	4,286
Total cash assets	8,524	11,819	12,550	11,402	4,674
Current liabilities	13,903	15,752	16,787	17,640	13,320
Cash Ratio, Comparison to Industry
AstraZeneca PLC¹	0.61	0.75	0.75	0.65	0.35
Industry, Health Care	0.66	0.69	0.70	0.69	0.56

Source: Based on data from AstraZeneca PLC Annual Reports

2012 Calculations

¹ Cash ratio = Total cash assets ÷ Current liabilities
= 8,524 ÷ 13,903 = 0.61

Ratio	Description	The company
Cash ratio	A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities.	AstraZeneca PLC's cash ratio improved from 2010 to 2011 but then deteriorated significantly from 2011 to 2012.